Comparative analysis of selected methods for the assessment of antimicrobial and membrane-permeabilizing activity: A case study for lactoferricin derived peptides

BMC Microbiology

Volumn 8, Issue , 2008, Pages

  Sánchez Gómez, Susana ^a   Lamata, Marta ^a   Leiva, José ^a,b   Blondelle, Sylvie E ^c   Jerala, Roman ^d   Andrä, Jörg ^e   Brandenburg, Klaus ^e   Lohner, Karl ^f   Moriyón, Ignacio ^a   Martínez De Tejada, Guillermo ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

^b UNIVERSITY CLINIC OF NAVARRA   (Spain)

^c TORREY PINES INSTITUTE FOR MOLECULAR STUDIES   (United States)

^d NATIONAL INSTITUTE OF CHEMISTRY   (Slovenia)

^e RESEARCH CENTER BORSTEL   (Germany)

^f ERICH SCHMID INSTITUTE OF MATERIALS SCIENCE   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; AMOXICILLIN; AMPICILLIN; ERYTHROMYCIN; FUSIDIC ACID; LACTOFERRICIN; NALIDIXIC ACID; NOVOBIOCIN; POLYMYXIN B; POLYPEPTIDE ANTIBIOTIC AGENT; POLYPROPYLENE; POLYSTYRENE; RIFAMPICIN; SOLVENT;

ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL CELL WALL; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; BACTERIOSTASIS; BORDETELLA BRONCHISEPTICA; BROTH DILUTION; CONTROLLED STUDY; ESCHERICHIA COLI; FLUORESCENCE; HYDROPHOBICITY; INTERMETHOD COMPARISON; MEMBRANE PERMEABILITY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PSEUDOMONAS AERUGINOSA; TURBIDIMETRY;

BACTERIA (MICROORGANISMS); PSEUDOMONAS AERUGINOSA;

EID: 78650421161     PISSN: 14712180     EISSN: 14712180     Source Type: Journal    
DOI: 10.1186/1471-2180-8-196     Document Type: Article

References (52)

1. Peptide antimicrobial agents. H Jenssen P Hamill RE Hancock, Clin Microbiol Rev 2006 19 491 511 16847082 10.1128/CMR.00056-05
2. Cationic host defense (antimicrobial) peptides. KL Brown RE Hancock, Curr Opin Immunol 2006 18 24 30 10.1016/j.coi.2005.11.004 16337365
3. Mechanisms of antimicrobial peptide action and resistance. MR Yeaman NY Yount, Pharmacol Rev 2003 55 27 55 10.1124/pr.55.1.2 12615953
4. The relationship between peptide structure and antibacterial activity. JP Powers RE Hancock, Peptides 2003 24 1681 1691 10.1016/j.peptides.2003.08.023 15019199
5. Molecular mechanisms of membrane perturbation by antimicrobial peptides and the use of biophysical studies in the design of novel peptide antibiotics. K Lohner SE Blondelle, Comb Chem High Throughput Screen 2005 8 241 256 10.2174/1386207053764576 15892626
6. Mechanisms of endotoxin neutralization by synthetic compounds. J Andrä T Gutsmann P Garidel K Brandenburg, J Endotoxin Res 2006 12 261 277 17059690
7. Multidrug-resistant bacteria: overcoming antibiotic permeability barriers of Gram-negative bacteria. PB Savage, Ann Med 2001 33 167 171 10.3109/07853890109002073 11370769
8. Agents that increase the permeability of the outer membrane. M Vaara, Microbiol Rev 1992 56 395 411 1406489
9. Expression of SMAP-29 cathelicidin-like peptide in bacterial cells by intein-mediated system. C Morassutti F De Amicis A Bandiera S Marchetti, Protein Expr Purif 2005 39 160 168 10.1016/j.pep.2004.11.006 15642466
10. Functional analysis of the alpha-defensin disulfide array in mouse cryptdin-4. A Maemoto X Qu KJ Rosengren H Tanabe A Henschen-Edman DJ Craik AJ Ouellette, J Biol Chem 2004 279 44188 44196 10.1074/jbc.M406154200 15297466
11. Sensitivity of Actinobacillus actinomycetemcomitans and Capnocytophaga spp. to the bactericidal action of LL-37: a cathelicidin found in human leukocytes and epithelium. D Tanaka KT Miyasaki RI Lehrer, Oral Microbiol Immunol 2000 15 226 231 10.1034/j.1399-302x.2000.150403.x 11154407
12. Susceptibilities of periodontopathogenic and cariogenic bacteria to antibacterial peptides, beta-defensins and LL37, produced by human epithelial cells. K Ouhara H Komatsuzawa S Yamada H Shiba T Fujiwara M Ohara K Sayama K Hashimoto H Kurihara M Sugai, J Antimicrob Chemother 2005 55 888 896 10.1093/jac/dki103 15886266
13. Staphylococcus aureus susceptibility to innate antimicrobial peptides, beta-defensins and CAP18, expressed by human keratinocytes. K Midorikawa K Ouhara H Komatsuzawa T Kawai S Yamada T Fujiwara K Yamazaki K Sayama MA Taubman H Kurihara K Hashimoto M Sugai, Infect Immun 2003 71 3730 3739 12819054 10.1128/IAI.71.7.3730-3739.2003
14. The outer membranes of Brucella spp. are resistant to bactericidal cationic peptides. G Martinez de Tejada J Pizarro-Cerda E Moreno I Moriyon, Infect Immun 1995 63 3054 3061 7622230
15. Brucellacidal activity of human and bovine polymorphonuclear leukocyte granule extracts against smooth and rough strains of Brucella abortus. LK Riley DC Robertson, Infect Immun 1984 46 231 236 6090316
16. Rationale for the design of shortened derivatives of the NK-lysin-derived antimicrobial peptide NK-2 with improved activity against Gram-negative pathogens. J Andrä D Monreal G Martinez de Tejada C Olak G Brezesinski S Sánchez-Gómez T Goldmann R Bartels K Brandenburg I Moriyon, J Biol Chem 2007 282 14719 14728 10.1074/jbc.M608920200 17389605
17. In vitro and in vivo activity of an antibacterial peptide analog against uropathogens. M Cudic CV Lockatell DE Johnson L Otvos Jr, Peptides 2003 24 807 820 10.1016/S0196-9781(03)00172-4 12948832
18. Development of novel LL-37 derived antimicrobial peptides with LPS and LTA neutralizing and antimicrobial activities for therapeutic application. MJ Nell GS Tjabringa AR Wafelman R Verrijk PS Hiemstra JW Drijfhout JJ Grote, Peptides 2006 27 649 660 10.1016/j.peptides.2005.09.016 16274847
19. In vitro susceptibility tests for cationic peptides: comparison of broth microdilution methods for bacteria that grow aerobically. A Giacometti O Cirioni F Barchiesi MS Del Prete M Fortuna F Caselli G Scalise, Antimicrob Agents Chemother 2000 44 1694 1696 10817731 10.1128/AAC.44.6.1694-1696.2000
20. Interaction of the cyclic antimicrobial cationic peptide bactenecin with the outer and cytoplasmic membrane. M Wu RE Hancock, J Biol Chem 1999 274 29 35 10.1074/jbc.274.1.29 9867806
21. Activity of natural antimicrobial compounds against Escherichia coli and Salmonella enterica serovar Typhimurium. NA Olasupo DJ Fitzgerald MJ Gasson A Narbad, Lett Appl Microbiol 2003 37 448 451 10.1046/j.1472-765X.2003.01427.x 14633097
22. Disinfectant testing: use of the Bioscreen Microbiological Growth Analyser for laboratory biocide screening. RJ Lambert MD Johnston EA Simons, Lett Appl Microbiol 1998 26 288 292 10.1046/j.1472-765X.1998.00334.x 9633095
23. In vitro studies of pharmacodynamic properties of vancomycin against Staphylococcus aureus and Staphylococcus epidermidis. E Lowdin I Odenholt O Cars, Antimicrob Agents Chemother 1998 42 2739 2744 9756787
24. Comparison of assays for detection of agents causing membrane damage in Staphylococcus aureus. AJ O'Neill K Miller B Oliva I Chopra, J Antimicrob Chemother 2004 54 1127 1129 10.1093/jac/dkh476 15531595
25. Use of the fluorescent probe 1-N-phenylnaphthylamine to study the interactions of aminoglycoside antibiotics with the outer membrane of Pseudomonas aeruginosa. B Loh C Grant RE Hancock, Antimicrob Agents Chemother 1984 26 546 551 6440475
26. Compounds which increase the permeability of the Pseudomonas aeruginosa outer membrane. REW Hancock PGW Wong, Antimicrob Agents Chemother 1984 26 48 52 6433788
27. Effect of polymyxin on the lysis of Neisseria catarrhalis by lysozyme. GH Warren J Cray J Yurchenko, J Bacteriol 1957 74 788 793 13502306
28. Actinomycin sensitivity in Escherichia coli produced by EDTA. L Leive, Biochem Biophys Res Commun 1965 18 13 17 10.1016/0006-291X(65)90874-0 14265747
29. Enhancement of endotoxin neutralization by coupling of a C12-alkyl chain to a lactoferricin-derived peptide. J Andrä K Lohner SE Blondelle R Jerala I Moriyon MH Koch P Garidel K Brandenburg, Biochem J 2005 385 135 143 15344905 10.1042/BJ20041270
30. Antimicrobial combinations. GM Eliopoulos RC Moellering, Antibiotics in Laboratory Medicine Baltimore: The Williams and Wilkins Co, Lorian V, 4 1996 330 396
31. Mechanisms of antibiotic resistance in Pseudomonas aeruginosa. PA Lambert, J R Soc Med 2002 95 Suppl 41 22 26 12216271
32. Efflux as a mechanism of resistance to antimicrobials in Pseudomonas aeruginosa and related bacteria: unanswered questions. HP Schweizer, Genet Mol Res 2003 2 48 62 12917802
33. Cell Walls of Pseudomonas Species Sensitive to Ethylenediaminetetraacetic Acid. SG Wilkinson, J Bacteriol 1970 104 1035 1044 16559075
34. Fluorometric assessment of Gram-negative bacterial permeabilization. IM Helander T Mattila-Sandholm, J Appl Microbiol 2000 88 2 213 9 10.1046/j.1365-2672.2000.00971.x 10735988
35. Impact of LL-37 on anti-infective immunity. DM Bowdish DJ Davidson YE Lau K Lee MG Scott RE Hancock, J Leukoc Biol 2005 77 451 459 10.1189/jlb.0704380 15569695
36. Temperature-regulated efflux pump/potassium antiporter system mediates resistance to cationic antimicrobial peptides in Yersinia. JA Bengoechea M Skurnik, Mol Microbiol 2000 37 67 80 10.1046/j.1365-2958.2000.01956.x 10931306
37. In vitro activities of designed antimicrobial peptides against multidrug-resistant cystic fibrosis pathogens. U Schwab P Gilligan J Jaynes D Henke, Antimicrob Agents Chemother 1999 43 1435 1440 10348766
38. Adsorption of nisin and enterocin 4 to polypropylene and glass surfaces and its prevention by Tween 80. HM Joosten M Nunez, Lett Appl Microbiol 1995 21 389 392 10.1111/j.1472-765X.1995.tb01089.x
39. Protegrin-1: a broad-spectrum, rapidly microbicidal peptide with in vivo activity. DA Steinberg MA Hurst CA Fujii AH Kung JF Ho FC Cheng DJ Loury JC Fiddes, Antimicrob Agents Chemother 1997 41 1738 1742 9257752
40. Effect of protein on ramnoplainin broth microdilution minimum inhibitory concentrations. R Scotti JK Dulworth MT Kenny BP Goldstein, Diagn Microbiol Infect Dis 1993 17 209 211 10.1016/0732-8893(93)90098-R 8112029
41. Sensitization of Gram-negative bacteria to antibiotics and complement by a nontoxic oligopeptide. M Vaara T Vaara, Nature 1983 303 526 528 10.1038/303526a0 6406904
42. Polyamines increase antibiotic susceptibility in Pseudomonas aeruginosa. DH Kwon CD Lu, Antimicrob Agents Chemother 2006 50 1623 1627 16641427 10.1128/AAC.50.5.1623-1627.2006
43. Enhancement by cationic compounds of the growth inhibitory effect of novobiocin on Escherichia coli. J Modha KJ Barrett-Bee RJ Rowbury, Lett Appl Microbiol 1989 8 219 222 10.1111/j.1472-765X.1989.tb00252.x
44. Antimicrobial activities of amine- and guanidine-functionalized cholic acid derivatives. C Li MR Lewis AB Gilbert MD Noel DH Scoville GW Allman PB Savage, Antimicrob Agents Chemother 1999 43 1347 1349 10348750
45. Antibacterial properties of cationic steroid antibiotics. PB Savage C Li U Taotafa B Ding Q Guan, FEMS Microbiol Lett 2002 217 1 7 10.1111/j.1574-6968. 2002.tb11448.x 12445638
46. Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria. LJ Piddock, Clin Microbiol Rev 2006 19 382 402 16614254 10.1128/CMR.19.2.382-402.2006
47. Sodium hexametaphosphate sensitizes Pseudomonas aeruginosa, several other species of Pseudomonas, and Escherichia coli to hydrophobic drugs. M Vaara J Jaakkola, Antimicrob Agents Chemother 1989 33 1741 1747 2511800
48. Antibacterial synergism of polymyxin B nonapeptide and hydrophobic antibiotics in experimental gram-negative infections in mice. I Ofek S Cohen R Rahmani K Kabha D Tamarkin Y Herzig E Rubinstein, Antimicrob Agents Chemother 1994 38 374 377 8192470
49. Group of peptides that act synergistically with hydrophobic antibiotics against gram-negative enteric bacteria. M Vaara M Porro, Antimicrob Agents Chemother 1996 40 1801 1805 8843284
50. In-vitro activity of cationic peptides alone and in combination with clinically used antimicrobial agents against Pseudomonas aeruginosa. A Giacometti O Cirioni F Barchiesi M Fortuna G Scalise, J Antimicrob Chemother 1999 44 641 645 10.1093/jac/44.5.641 10552980
51. Effect of siliconized latex urinary catheters on the activity of carbapenems against Pseudomonas aeruginosa strains with defined mutations in ampC, oprD, and genes coding for efflux systems. MC Conejo L Martínez-Martínez I García L Picabea A Pascual, Int J Antimicrob Agents 2003 22 122 127 10.1016/S0924-8579(03)00119-5 12927951
52. National Committee for Clinical Laboratory Standards, Approved Standard: M7-A6. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically Wayne, PA, USA 2003